Cognition Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.About CGTX
Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions.
CEOLisa R. Ricciardi
CEOLisa R. Ricciardi
Employees28
Employees28
HeadquartersPurchase, New York
HeadquartersPurchase, New York
Founded2007
Founded2007
Employees28
Employees28
CGTX Key Statistics
Market cap154.92M
Market cap154.92M
Price-Earnings ratio-3.71
Price-Earnings ratio-3.71
Dividend yield—
Dividend yield—
Average volume1.02M
Average volume1.02M
High today$1.85
High today$1.85
Low today$1.72
Low today$1.72
Open price$1.79
Open price$1.79
Volume940.05K
Volume940.05K
52 Week high$3.83
52 Week high$3.83
52 Week low$0.2223
52 Week low$0.2223
Stock Snapshot
With a market cap of 154.92M, Cognition Therapeutics(CGTX) trades at $1.76. The stock has a price-to-earnings ratio of -3.71.
On 2025-12-05, Cognition Therapeutics(CGTX) stock traded between a low of $1.72 and a high of $1.85. Shares are currently priced at $1.76, which is +2.3% above the low and -4.9% below the high.
The Cognition Therapeutics(CGTX)'s current trading volume is 940.05K, compared to an average daily volume of 1.02M.
In the last year, Cognition Therapeutics(CGTX) shares hit a 52-week high of $3.83 and a 52-week low of $0.22.
In the last year, Cognition Therapeutics(CGTX) shares hit a 52-week high of $3.83 and a 52-week low of $0.22.
People also own
Based on the portfolios of people who own CGTX. This list is generated using Robinhood data, and it’s not a recommendation.